Bladder Bank (a Prospective Banking Study)
Summary
This study collects blood and urine samples from patients with bladder cancer to support the development of tests for early detection of bladder cancer.
Detailed description
PRIMARY OBJECTIVE: I. To establish a biobank of samples (blood and urine) to support the development of non-invasive tests for early detection of bladder cancer. OUTLINE: This is an observational study. Patients undergo blood and urine sample collection and have their medical records reviewed while on study.
Arms & interventions
- OtherNon-Interventional Study
Non-interventional study
Outcome measures
Primary
Blood sample to support the development of non-invasive tests for early detection of bladder cancer
At study enrollment for subjects, 60 ml (4 tablespoons) of blood will be drawn from all participants and processed according to standardized study biospecimen protocol. All samples will be stored for future analysis in Molecular Cancer Diagnostic Laboratory at Mayo Clinic.
Time frame: Baseline (at enrollment)
Urine sample to support the development of non-invasive tests for early detection of bladder cancer
At study enrollment for subjects, up to 20mL of urine will be collected from the same or unique case patients identified for blood collection. All samples will be stored for future analysis in Molecular Cancer Diagnostic Laboratory at Mayo Clinic.
Time frame: Baseline (at enrollment)
Eligibility criteria
Study locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, 55905